E
BioNTech SE BNTX
$105.07 -$5.81-5.24% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income 49.54% -27.92% -43.89% 24.59% -319.53%
Total Depreciation and Amortization 7.77% 8.33% 107.83% 8.59% 54.68%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items -398.40% 103.24% -247.62% -591.61% 112.01%
Change in Net Operating Assets -76.06% -281.46% -474.99% -206.68% -50.28%
Cash from Operations -90.51% -138.51% -153.91% -179.55% -63.32%
Capital Expenditure 67.75% 18.97% 21.21% -36.17% -30.37%
Sale of Property, Plant, and Equipment 163.59% -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 73.95% 159.29% 125.50% 91.64% 93.20%
Cash from Investing 71.87% 152.45% 122.29% 88.35% 89.58%
Total Debt Issued -- -- -- -- --
Total Debt Repaid 41.92% -76.92% 40.65% 15.96% -143.62%
Issuance of Common Stock -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing 38.76% -71.51% 43.97% 97.43% 86.14%
Foreign Exchange rate Adjustments 393.96% -329.52% 109.63% -103.80% -103.58%
Miscellaneous Cash Flow Adjustments -82.82% 80.13% -107.45% -- --
Net Change in Cash -93.63% 115.26% 107.42% -13.25% -31.55%